While a reduction in TAPBP expression has been associated to tumor progression in colorectal cancer and chronic hepatitis B [41,42], the rs2071888 SNP has been associated with wild type gastrointestinal tumors and gallbladder cancer [43,44]. This evidence concerns the gene TAPBP and digestive system neoplasm.